Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$160.79−0.31 (-0.19%)
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis Core Net Income: $4,655M in Q3 2026, up 7.5% from a year earlier.
Latest, Q3 2026
4,655
Period ended Sep 30, 2026
Change on a year earlier
+7.5%
4,330 in Q3 2025
History
11 quarters
Since Q1 2024
Sources
7
Documents cited below
Where the Q3 2026 figure comes from
“|| Core net income | 4 655 | 4 330 | 8 | 6 | 13 027 | 13 522 | -4 | -5”
Source: Novartis Form 6-K (0001114448-26-000014) ↗
Reported in Form 6-K.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Core Net Income ($M) | Year on year | Source |
|---|---|---|---|---|
| Q3 2026 | Sep 30, 2026 | 4,655 | +7.5% | Novartis Form 6-K (0001114448-26-000014) ↗ |
| Q2 2026 | Jun 30, 2026 | 4,578 | -2.8% | Novartis Form 6-K (0001114448-26-000012) ↗ |
| Q1 2026 | Mar 31, 2026 | 3,794 | -15.4% | Novartis Form 6-K (0001114448-26-000010) ↗ |
| Q4 2025 | Dec 31, 2025 | 3,889 | -1.1% | Novartis Form 6-K (0001114448-26-000007) ↗ |
| Q3 2025 | Sep 30, 2025 | 4,330 | +4.8% | Novartis Form 6-K (0001114448-26-000014) ↗ |
| Q2 2025 | Jun 30, 2025 | 4,710 | +17.5% | Novartis Form 6-K (0001114448-26-000012) ↗ |
| Q1 2025 | Mar 31, 2025 | 4,482 | +21.8% | Novartis Form 6-K (0001114448-26-000010) ↗ |
| Q4 2024 | Dec 31, 2024 | 3,933 | – | Novartis Form 6-K (0001114448-26-000007) ↗ |
| Q3 2024 | Sep 30, 2024 | 4,133 | – | Novartis Form 6-K (0001114448-25-000003) ↗ |
| Q2 2024 | Jun 30, 2024 | 4,008 | – | Novartis Form 6-K (0001370368-25-000012) ↗ |
| Q1 2024 | Mar 31, 2024 | 3,681 | – | Novartis Form 6-K (0001370368-25-000010) ↗ |
Breakdown
What makes up core Net Income
Cite this data
StockData. (2026). Novartis Core Net Income ($M), quarterly Q1 2024–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/core-net-income
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.